| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2002 | CA2439286A1 Carbamate compounds for use in preventing or treating anxiety disorders |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2439261A1 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease |
| 09/06/2002 | CA2439256A1 (z)-styrylbenzylsulfones and pharmaceutical uses thereof |
| 09/06/2002 | CA2439150A1 Avilamycin derivatives |
| 09/06/2002 | CA2439143A1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2439053A1 Hiv inhibiting n-aminoimidazole derivatives |
| 09/06/2002 | CA2438960A1 Influenza vaccine formulations for intradermal delivery |
| 09/06/2002 | CA2438932A1 Compositions and methods for cancer prevention and treatment derived from inula britannica |
| 09/06/2002 | CA2438930A1 Treatment of tics, tremors and related disorders |
| 09/06/2002 | CA2438907A1 Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| 09/06/2002 | CA2438899A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | CA2438890A1 Novel substituted imidazotriazinones |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | CA2438824A1 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 09/06/2002 | CA2438696A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | CA2438630A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | CA2438268A1 Modulation of release from dry powder formulations |
| 09/06/2002 | CA2438193A1 Novel dendritic polymers and their biomedical uses |
| 09/06/2002 | CA2438063A1 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 09/06/2002 | CA2437417A1 Thiol-modified hyaluronan |
| 09/06/2002 | CA2437114A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | CA2435815A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
| 09/06/2002 | CA2435739A1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 09/06/2002 | CA2434727A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | CA2434654A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | CA2433776A1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2432287A1 Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2431038A1 6-substituted pyrazolo¬3,4-d|pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/06/2002 | CA2410802A1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 09/05/2002 | US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/05/2002 | US20020123638 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 09/05/2002 | US20020123637 Pharmaceutically active compounds and methods of use thereof |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123532 E.g., bis(3,5-dibromo-2,4,6-trihydroxyphenyl)squaraine and bis(3,5- diiodo-2,4,6-trihydroxyphenyl)squaraine; anticarcinogenic and-tumor agents; fluorescent detector of tumors; sterilization of water; stability; nontoxic |
| 09/05/2002 | US20020123531 Purging malignant cells from a mixture with nonmalignant cells by radiating the dye to photoactivate it; elimination of residual tumor cells from autologous bone marrow grafts with minimum toxicity toward normal cells |
| 09/05/2002 | US20020123530 Use of crystal violet as photochemotherapeutic agent |
| 09/05/2002 | US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia |
| 09/05/2002 | US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC |
| 09/05/2002 | US20020123526 Inhibitor of replicative senescence of human keratinocytes containing retinoic acid as active ingredients |
| 09/05/2002 | US20020123525 Protecting a heart against oxidative stress by administering a synergistic composition comprising pyruvate, a compound imparting oxidation resistance and a lipid(s), e.g. fatty acid; heart attack, failure; antiischemic agents; transplants |
| 09/05/2002 | US20020123524 Treatment of vascular events using lipid-modifying compositions |
| 09/05/2002 | US20020123522 Inhibition of inflammation using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors |
| 09/05/2002 | US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123519 Amlodipine fumarate |
| 09/05/2002 | US20020123518 Amide derivative of amlodipine |
| 09/05/2002 | US20020123517 Method for controlling cell necrosis or apoptosis |
| 09/05/2002 | US20020123516 Synergistic mixture of idebenone and nimodipine |
| 09/05/2002 | US20020123514 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123512 Pharmaceutical composition |
| 09/05/2002 | US20020123511 Paroxetine adsorbed or absorbed on a solid carrier to form a free-flowing powder useful for capsule filling or for tablet formation; treating depression |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123508 Cyclohexane carbocyclic ester derivative and cyclodextrin complex and composition for treatment of helicobacter pylori infections |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | US20020123505 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 09/05/2002 | US20020123504 In an inert carrier; instant release; treating allergic rhinitis and other histamine-induced disorders |
| 09/05/2002 | US20020123501 Useful for premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/05/2002 | US20020123500 CSAIDs.TM block cytokine production; use of a cytokine inhibitor for the treatment of chronic diseases which are caused by inappropriate angiogenesis, such as diabetic retinopathy, tumors, atherosclerosis and arthritis |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123496 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/05/2002 | US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | US20020123492 Beta-amino acid derivatives |
| 09/05/2002 | US20020123490 Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis |
| 09/05/2002 | US20020123489 Benzamidine derivatives |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123486 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 09/05/2002 | US20020123485 For therapy of hypertension, cirrhosis and ascites |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123483 IL-8 receptor ligands - drugs for inflammatory and autoimmune diseases |
| 09/05/2002 | US20020123480 Administering 2',5'-oligoadenylate-2',3'-cyclophosphate compound for therapy of disorder of cell proliferation |
| 09/05/2002 | US20020123478 Synthetic transfection vectors |
| 09/05/2002 | US20020123476 For treating infectious diseases and genetic disorders through gene therapy and intracellular delivery of antisense oligonucleotides or other nucleic acid sequences |
| 09/05/2002 | US20020123473 For therapy of asthma |
| 09/05/2002 | US20020123470 Administering aminoglycoside antibiotic compound for therapy of ophthalmic disease caused by premature stop mutations in a gene |
| 09/05/2002 | US20020123469 Antiproliferative colchicine compositions and uses thereof |
| 09/05/2002 | US20020123460 Compositions for stabilizing oxygen-labile species |
| 09/05/2002 | US20020123440 Foamable antimicrobial formulation |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020122857 Adding an organic solvent to an aqueous extract of soybeans and purifying precipitate |
| 09/05/2002 | US20020122835 Zinc, magnesium and vitamin B6; especially zinc monomethionine, zinc aspartate and magnesium aspartate; may also contain theanine |
| 09/05/2002 | US20020122834 Method and composition for improving fertility health in female and male animals and humans |
| 09/05/2002 | US20020122827 Atomizing liquid solutions of the macromolecules, drying the droplets, and collecting the particles; process control; especially for proteins, a nucleic acids, and a high molecular weight polysaccharides. |
| 09/05/2002 | US20020122824 Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids |
| 09/05/2002 | US20020122822 Having a friability of less than about 2% from an active ingredient, an excipient in the form of a hydrate, and a water- swellable excipient; and applying energy to decrease the hardness of the tablet by at least 20%. |
| 09/05/2002 | US20020122821 Spermine antagonists inhibit the inhibitory effect of spermine upon macrophage function, and prevent spermine induced immunosuppression; combination of a bispiperidine a diamine or dinitrile |